Advanced search
Publication Cover
Modern Rheumatology Volume 18, 2008 - Issue 3
Journal homepage
28
Views
2
CrossRef citations to date
0
Altmetric
Case Report

Efficacy and safety of tacrolimus treatment for rheumatoid arthritis patients undergoing hemodialysis

Misuzu YamashitaDepartment of Medicine, Kurashiki Kosai Hospital, 5-4-16 Higashiduka, Kurashiki, Okayama 712-8044, Japan
,
Masamitsu NatsumedaDepartment of Medicine, Kurashiki Kosai Hospital, 5-4-16 Higashiduka, Kurashiki, Okayama 712-8044, JapanCorrespondence[email protected]
,
Koji TakasugiDepartment of Medicine, Kurashiki Kosai Hospital, 5-4-16 Higashiduka, Kurashiki, Okayama 712-8044, Japan
,
Akiko UenoDepartment of Medicine, Kurashiki Kosai Hospital, 5-4-16 Higashiduka, Kurashiki, Okayama 712-8044, Japan
,
Kayo EzawaDepartment of Medicine, Kurashiki Kosai Hospital, 5-4-16 Higashiduka, Kurashiki, Okayama 712-8044, Japan
&
Kazuhiko EzawaDepartment of Medicine, Kurashiki Kosai Hospital, 5-4-16 Higashiduka, Kurashiki, Okayama 712-8044, Japan
Pages 296-300 | Received 02 Oct 2007, Accepted 28 Dec 2007, Published online: 02 Jan 2014

References

  • Basile C, Basile C, Semeraro A. Should low-dose methotrexate therapy be prescribed to dialysis patients? Nephrol Dial Trans-plant. 2002;17:530–31.
  • Beaman JM, Hackett LP, Luxton G, Illett KF. Effect of hemod-ialysis on leflunomide plasma concentrations. Ann Pharmacother. 2002;36:75–7.
  • Iwamoto M, Homma S, Asano Y, Minota S. Administration of leflunomide to a patient with rheumatoid arthritis on haemodi-alysis. Scand J Rheumatol. 2005;34:410–1.
  • Don BR, Spin G, Nestorov I, Hutmacher M, Rose A, Kaysen GA. The pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis. J Pharm Pharmacol. 2005;57: 1407–13.
  • Tanaka Y, Suzuki K, Saito K. Efficacy of tacrolimus for joint destruction in rheumatoid arthritis. Clin Calcium. 2007;17:593–9.
  • Venkataramanan R, Jain A, Cadoff E, Warty V, Iwasaki K, Nagase K et al. Pharmacokinetics of FK 506: precfinical and clinical studies. Transplant Proc.1990;22:52–6.
  • Venkataramanan R, Jain A, Warty VW, Abu-Elmagd K, Furak-awa H, Imventarza 0 et al. Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine. Transplant Proc. 1991;23: 931–3.
  • Shiraga T, Matsuda H, Nagase K, Iwasaki K, Noda K, Yamazaki H et al. Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes. Biochem Pharmacol. 1994;47:727–35.
  • Moller A, Iwasaki K, Kawamura A, Teramura Y, Shiraga T, Hata T et al. The disposition of 14C-labeled tacrolimus after intrave-nous and oral administration in healthy human subjects. Drug Metab Dispos. 1999;27:633–6.
  • Furst DE, Saag K, Fleischmann MR, Sherrer Y, Block JA, Schnitzer T et al. Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study. Arthritis Rheum. 2002;46:2020–8.
  • Yocum DE, Furst DE, Bensen WG, Burch FX, Borton MA, Mengle-Gaw LJ et al. Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience. Rheumatology (Oxford). 2004;43:992–9.
  • Bressolle F, Bologna C, Kinowski JM, Sany J, Combe B. Effects of moderate renal insufficiency on pharmacokinetics of metho-trexate in rheumatoid arthritis patients. Ann Rheum Dis. 1998;57:110–3.
  • Wall SM, Johansen MJ, Molony DA, DuBose TD, Jaffe N, Madden T. Effective clearance of methotrexate using high-flux hemodialysis membranes. Am J Kidney Dis. 1996;28:846–54.
  • Singh R, Cuchacovich R, Huang W, Espinoza LR. Infliximab treatment in a patient with rheumatoid arthritis on hemodialysis. J Rheumatol. 2002;29:636–7.
  • Hammoudeh M. Infliximab treatment in a patient with rheuma-toid arthritis on haemodialysis. Rheumatology (Oxford). 2006;45: 357–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.